Name: Latest research reports of J B Chemicals & Pharmaceuticals Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: J B Chemicals & Pharmaceuticals Ltd.
Rating: 4
Author: ICICI Securities Limited

J B Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM | BSE: 506943 | ISIN: INE572A01036 | Industry: Pharmaceuticals
| Mid-range Performer

1738.0000 -31.30 (-1.77%)

NSE Aug 01, 2025 15:31 PM

25.42% Gain from 52W Low

Volume: 376.5K

J B Chemicals & Pharmaceuticals Ltd.

10 Feb 2023

1738.00

-1.77%

In-line performance

Accumulate: J B Chemicals & Pharmaceut...

Target

ICICI Securities Limited

JB Chemicals & Pharmaceuticals (JBCPL) Q3FY23 performance was broadly in line with our estimates, driven by robust growth across the segments. Consolidated revenue grew 32% YoY to Rs7.9bn (I-Sec: 7.7bn) driven by acquisitions in India.

Number of FII/FPI investors decreased from 319 to 311 in Jun 2025 qtr

The Baseline | 01 Aug 2025, 05:05PM

Market closes lower, Godrej Properties' revenue beats Forecaster estimates by 40% in Q1

Trendlyne Marketwatch | 01 Aug 2025, 03:57PM

New leadership, fresh strategy at JB Chemicals sees impact in Q1FY23

| 09 Sep 2022